Welty, Francine K.

Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association

Duell, P. B., Welty, F. K., Miller, M., Chait, A., Hammond, G., Ahmad, Z., Cohen, D. E., Horton, J. D., Pressman, G. S., Toth, P. P., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 727

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association

Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation

Fatty Acid Research and HealthLipid metabolism and disorders

Cited by 512

Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association

Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation

Sex and Gender in HealthcareDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 334

Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association

Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 304

Targeting inflammation in metabolic syndrome

Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research

Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 287

How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?

Welty, F. K. (2013) · Current Cardiology Reports

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 221

Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling

Elajami, T. K., Colas, R. A., Dalli, J., Chiang, N., Serhan, C. N., & Welty, F. K. (2016) · The FASEB Journal

Fatty Acid Research and HealthEicosanoids and Hypertension Pharmacology

Cited by 143

Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease

Wenger, N. K., Lewis, S. J., Herrington, D. M., Bittner, V., Welty, F. K., & for the Treating to New Targets Study Steering Committee and Investigators (2007) · Annals of Internal Medicine

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 139

Effect of Soy Nuts on Adhesion Molecules and Markers of Inflammation in Hypertensive and Normotensive Postmenopausal Women

Nasca, M. M., Zhou, J.-R., & Welty, F. K. (2008) · The American Journal of Cardiology

Phytoestrogen effects and researchNuts composition and effects

Cited by 73

Nonstatin Low-Density Lipoprotein–Lowering Therapy and Cardiovascular Risk Reduction—Statement From ATVB Council

Hegele, R. A., Gidding, S. S., Ginsberg, H. N., McPherson, R., Raal, F. J., Rader, D. J., Robinson, J. G., & Welty, F. K. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 63

Cholesterol and apolipoprotein B metabolism in Tangier disease

Schaefer, E. J., Brousseau, M. E., Diffenderfer, M. R., Cohn, J. S., Welty, F. K., O'Connor, J., Dolnikowski, G. G., Wang, J., Hegele, R. A., & Jones, P. J. (2001) · Atherosclerosis

Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular Health

Cited by 52

Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans

Marsh, J. B., Welty, F. K., & Schaefer, E. J. (2000) · Current Opinion in Lipidology

Cholesterol and Lipid MetabolismLipid metabolism and disorders

Cited by 38

Influence of the DASH diet and other low-fat, high-carbohydrate diets on blood pressure

Delichatsios, H. K., & Welty, F. K. (2005) · Current Atherosclerosis Reports

Sodium Intake and HealthBlood Pressure and Hypertension Studies

Cited by 15

Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals

Abuknesha, N. R., O’Keefe, J. H., Qian, F., Tintle, N. L., Lin, Y., Sun, Y., Qian, H.-Z., Aisen, P. S., Albert, C. M., Aronson, W. J., et al. (2026) · Circulation: Arrhythmia and Electrophysiology

Fatty Acid Research and HealthAtrial Fibrillation Management and Outcomes

Cited by 1